Mackenzie Financial
IOVA icon

Mackenzie Financial’s Iovance Biotherapeutics IOVA Stock Holding History

Mackenzie Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,360
Closed -$45.2K – 1583
2025
Q4 		$45.2K Sell
16,360
-1,127
-6% -$2.61K ﹤0.01% 1621
2025
Q3 		$37.9K Hold
17,487
– – ﹤0.01% 1665
2025
Q2 		$30.1K Hold
17,487
– – ﹤0.01% 1663
2025
Q1 		$58.2K Hold
17,487
– – ﹤0.01% 1618
2024
Q4 		$129K Buy
17,487
+1,540
+10% +$14.3K ﹤0.01% 1613
2024
Q3 		$150K Buy
15,947
+1,784
+13% +$16.9K ﹤0.01% 1435
2024
Q2 		$114K Hold
14,163
– – ﹤0.01% 1418
2024
Q1 		$210K Buy
+14,163
New +$165K ﹤0.01% 1327
2023
Q2 		– Sell
-60,571
Closed -$370K – 1573
2023
Q1 		$370K Buy
+60,571
New +$418K ﹤0.01% 1112
2022
Q3 		– Sell
-10,325
Closed -$114K – 1483
2022
Q2 		$114K Buy
+10,325
New +$135K ﹤0.01% 1333

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return